Stryker vs. Zimmer Biomet vs. Johnson & Johnson: How they compare in Q2 2023

Spinal Tech

Stryker, Johnson & Johnson and Zimmer Biomet posted their second quarter financial results for 2023, and data on their orthopedic sales.

Here is how they compare:

Stryker

Total sales: $5 billion (+11.2 percent)

Orthopedics and spine: $2.1 billion (+9.9 percent)

Hips: $393 million (+8.1 percent)

Knees: $562 million (+12.5 percent)

Spine: $296 million (+1.8 percent)

Johnson & Johnson

Total sales: $25.5 billion (+6.3 percent)

Spine, sports and other: $766 million (+5.8 percent)

Orthopedic: $2.3 billion (+5 percent)

Hips: $397 million (+2.2 percent)

Knees: $363 million (+3.9 percent)

Zimmer Biomet

Total sales: $1.8 billion (+4.9 percent)

Hips: $504.3 million (+3.5 percent)

Knees: $771.4 million (+9.4 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $442.7 (-0.8 percent)

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers